Post Tagged with: "Acute lymphoblastic leukaemia (ALL)"

Novel Immunotherapy Agents for Acute Lymphoblastic Leukaemia

Novel Immunotherapy Agents for Acute Lymphoblastic Leukaemia

European Medical Journal, Hematology August 31, 2017 at 8:14 AM 0 comments

*David Pesántez,1 Adela Rodriguez,1 Aina Oliver-Caldés,2 Pablo Mozas,2 Jordi Esteve2-4 1. Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain 2. Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain 3. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain 4. University of Barcelona, Barcelona, Spain *Correspondence to pesantez@clinic.cat Disclosure:Read More

Editor’s Pick: The Role and Regulation of Quiescence in Acute Lymphoblastic Leukaemia

Editor’s Pick: The Role and Regulation of Quiescence in Acute Lymphoblastic Leukaemia

Hematology August 8, 2017 at 8:26 AM 0 comments

In this comprehensive review, emerging research regarding the role of quiescence in the causation of acute lymphoblastic leukaemia relapse is explored. This paper by Williams and Gordon provides a valuable opportunity to gain a deeper understanding of the poor prognosis for those children who relapse, and allows us to understandRead More

The Role of Allograft in Acute Lymphoblastic Leukaemia, Including Alternate Donors

The Role of Allograft in Acute Lymphoblastic Leukaemia, Including Alternate Donors

Hematology August 8, 2017 at 8:24 AM 0 comments

*Julian Cooney Department of Haematology, Fiona Stanley Hospital, Murdoch, Perth, Australia; University of Western Australia, Crawley, Perth, Australia *Correspondence to Julian.Cooney@health.wa.gov.au Disclosure: The author has declared no conflicts of interest. Received: 07.04.17 Accepted: 10.07.17 Citation: EMJ Hematol. 2017;5[1]:87-94. Abstract The management of acute lymphoblastic leukaemia (ALL) remains challenging. The changingRead More

Current Management of Adult Acute Lymphoblastic Leukaemia: Emerging Insights and Outstanding Questions

Current Management of Adult Acute Lymphoblastic Leukaemia: Emerging Insights and Outstanding Questions

Hematology July 28, 2016 at 8:20 AM 0 comments

*Xavier Thomas, Caroline Le Jeune Hematology Department, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France *Correspondence to xavier.thomas@chu-lyon.fr Disclosure: The authors have declared no conflicts of interest. Received: 21.03.16 Accepted: 28.06.16 Citation: EMJ Hematol. 2016;4[1]:117-128. Abstract Less than 50% of patients with adult acute lymphoblastic leukaemia (ALL)Read More